{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-25-000039","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2025-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.095863+00:00","generated_at":"2026-05-26T23:29:14.134155+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"GRI Bio shareholders authorize reverse stock split at ratio of 1:2 to 1:23","bullets":["Special meeting held Feb 11, 2025; quorum of 4,640,469 shares (51.94%) present.","Reverse split proposal approved: 3,151,775 for, 1,484,078 against, 4,616 abstain.","Board may set exact ratio within 1:2 to 1:23 range and can abandon split entirely.","Adjournment proposal also approved: 3,237,240 for, 1,390,423 against, 12,806 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-25-000039","json":"https://secwatch.observer/filing/0001824293-25-000039.json","markdown":"https://secwatch.observer/filing/0001824293-25-000039.md","text":"https://secwatch.observer/filing/0001824293-25-000039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000039/0001824293-25-000039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429325000039/val-20250211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:29:14.134155+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}